Palbociclib Plus Letrozole Treatment After Progression to Second Line Chemotherapy for Women With ER/PR-positive Ovarian Cancer
Clinical trial NCT03936270 · COMPLETED
Trial details
- NCT number
- NCT03936270
- Sponsor
- Latin American Cooperative Oncology Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-05
- Primary completion
- 2022-01-18
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.